On assessing excess mortality in Germany during the COVID-19 pandemic
Giacomo De Nicola, G\"oran Kauermann, Michael H\"ohle

TL;DR
This paper develops methods to accurately estimate excess mortality in Germany during COVID-19 by comparing observed deaths with expected figures, emphasizing age-specific analysis to better understand the pandemic's impact.
Contribution
It introduces two novel approaches for calculating expected and excess mortality at weekly and yearly levels, incorporating age stratification for more precise assessment.
Findings
Age-specific excess mortality was quantified for Germany in 2020.
The methods reveal variations in mortality across different age groups.
The approaches improve accuracy over traditional excess mortality estimation techniques.
Abstract
Coronavirus disease 2019 (COVID-19) is associated with a very high number of casualties in the general population. Assessing the exact magnitude of this number is a non-trivial problem, as relying only on officially reported COVID-19 associated fatalities runs the risk of incurring in several kinds of biases. One of the ways to approach the issue is to compare overall mortality during the pandemic with expected mortality computed using the observed mortality figures of previous years. In this paper, we build on existing methodology and propose two ways to compute expected as well as excess mortality, namely at the weekly and at the yearly level. Particular focus is put on the role of age, which plays a central part in both COVID-19-associated and overall mortality. We illustrate our methods by making use of age-stratified mortality data from the years 2016 to 2020 in Germany to compute…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Insurance, Mortality, Demography, Risk Management · Global Health Care Issues
